Drugs / 5-aza-deoxycytidine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT01417767 Comparator | Sep 2011 → Sep 2013 | myelodysplastic syndrome | Xiao Li | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 5-aza-deoxycytidine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01417767 ↗ |
| Known as | Decitabine | “one course of Decitabine (5-aza-deoxycytidine,Dacogen)” NCT01417767 ↗ |